Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BREATH study of rocuronium-induced partial neuromuscular block and reversal with sugammadex or neostigmine
NL-OMON27296Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2017
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial comparing Rocuronium + placebo, Rocuronium + neostigmine and Rocuronium + sugammadex (3 arms). Started Jun 2017; status: recruiting.
02
Drugs
rocuroniumSugammadexneostigmine
Beyond the preview
Go deeper on NL-OMON27296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27296.